ASCO Genitourinary Cancers Symposium | Conference

Sumanta K. Pal, MD, FASCO, on CONTACT-03 Trial and Investigating Targeted Therapy, Immunotherapy for Patients with RCC
March 12, 2021

Pal detailed the plan for the CONTACT-03 study and what the research team hopes to see with the data.

Michael Szarek, PhD, on Research Areas of Focus for Tivozanib in RCC
March 11, 2021

The expert from SUNY Downstate Medical Center spoke about areas of research for renal cell carcinoma which he believes deserve further attention.

Sumanta K. Pal, MD, FASCO, on Moving Forward with Cabozantinib as Treatment for Patients with RCC
March 10, 2021

Pal discussed the emergence of cabozantinib as a treatment option for patients with renal cell carcinoma and touched on future research around the drug.